NWNaidong Weng

Naidong Weng

*This is an algorithmically generated author record based on publicly available information.

Naidong Weng has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Strategic Framework for Optimized Bioanalytical Outsourcing: An Integrated Approach to Assay Development, CRO Selection, and Performance Governance

    by Kai Wang, Zhuo Chen, Melanie Chalfant, Andria Culbert, Chenmei Hou, Ciara Seal, Erica Hess, Gareth Satchell, Kevin McKinski, Rena Zhang, et al.

  • Meeting Report on the 3rd Chinese American Society for Mass Spectrometry Conference—Advancing Biological and Pharmaceutical Mass Spectrometry

    by Hao Chen, Yunlin Fu, Mei Han, Xianlin Han, Ling Hao, Tao Huan, Lan Huang, Ming Huang, Qin Ji, Tao Jiang, et al.

    Following the highly successful Chinese American Society for Mass Spectrometry (CASMS) conferences in the previous 2 years, the 3rd CASMS Conference was held virtually on August 28–31, 2023, using the Gather.Town platform to bring together scientists in the MS field. The conference offered a 4‐day agenda with a scientific program consisting of two plenary lectures, and 14 parallel symposia in which a total of 70 speakers presented technological innovations and their applications in proteomics and biological MS and metabo‐lipidomics and pharmaceutical MS. In addition, 16 invited speakers/panelists presented at two research‐focused and three career development workshops. Moreover, 86 posters, 12 lightning talks, 3 sponsored workshops, and 11 exhibitions were presented, from which 9 poster awards and 2 lightning talk awards were selected. Furthermore, the conference featured four young investigator awardees to highlight early‐career achievements in MS from our society. The conference provided a unique scientific platform for young scientists (i.e. graduate students, postdocs, and junior faculty/investigators) to present their research, meet with prominent scientists, learn about career development, and job opportunities (http://casms.org).

  • Quantitation of P450 3A4 endogenous biomarker – 4β‐hydroxycholesterol – in human plasma using LC/ESI‐MS/MS

    by Mike‐Qingtao Huang, Weisheng Lin, Weimin Wang, Wei Zhang, Zhongping (John) Lin, Naidong Weng

    4β‐Hydroxycholesterol (4β‐HC) has been proposed as a new endogenous biomarker for cytochrome P450 3A4/5 activity. Therefore, it is important to have a robust method for its accurate determination in human plasma. Here a liquid chromatography–tandem mass spectrometry with electrospray ionization (LC/ESI‐MS/MS) assay for the quantitation of 4β‐HC in human plasma is described. While the calibration standards were prepared in a surrogate matrix for human plasma, the quality control samples were prepared in human plasma to mimic the incurred study samples. In order to achieve accurate determination of 4β‐HC, the chromatographic separation of 4β‐HC from its isomers, especially 4α‐hydroxycholesterol (4α‐HC), was crucial. In the absence of an authentic 4α‐HC standard at the time of this study, an alternative selectivity test strategy was developed to confirm the separation. After being alkalized with potassium hydroxide, the human plasma sample (50 μL) was extracted with hexane, derivatized into picolinyl esters using picolinic acid, extracted again with hexane, and then analyzed by LC/ESI‐MS/MS. The calibration curve range was 5–500 ng/mL and the chromatographic separation was achieved on a 50 × 2.1 mm Thermal Hypersil Gold column with a gradient elution. The assay accuracy, precision, linearity, selectivity and analyte stability throughout the analysis were established. The validated assay was successfully applied to a Phase I clinical study for the measurement of 4β‐HC in human plasma. Copyright © 2014 John Wiley & Sons, Ltd.


  • Quantitative Analysis of Minocycline by Liquid Chromatography on Poly(styrene-divinylbenzene)

    by Weng Naidong, J. Thuranira, K. Vermeulen, E. Roets, J. Hoogmartens

    An isocratic liquid chromatographic method has been developed for assay and purity control of minocycline. All the potential impurities are well separated from the main component and from each other. The stationary phase is poly(styrene-divinylbenzene) (PSDVB), PLRP-S, 250 mm × 4.6 mm, which is heated at 60 °C. The mobile phase is 2-methyl-2-propanol (x g/100 ml) - 0.2 M potassium phosphate buffer pH 10.5 (10.0 ml) - 0.02 M tetrabutylam-monium sulphate pH 10.5 (10.0 ml) - 0.01 M sodium edetate pH 10.5 (10.0 ml) - water (up to 100 ml). The flow rate is 1.0 ml/min and UV detection is performed at 254 nm. The total analysis time does not exceed 30 min. Official standards were compared and a number of commercial bulk samples and specialties were analysed. 4-Epiminocycline, 6-deoxy-6-demethyltetracycline and 7-monodemethyl-minocycline are the main impurities. 7-Didemethylminocy-cline, 9-minocycline and some impurities of unknown identity also can be present.